INVESTING IN THE FUTURE OF CANNABIS

Press Releases

May 15, 2020

PharmaCielo Ltd. Obtains Final Receipt for Short Form Prospectus
May 12, 2020

PharmaCielo Welcomes Dr. Claudia Jiménez to Board of Directors
May 4, 2020

PharmaCielo Adds Experienced Senior Leader to Executive Team
Apr 30, 2020

PharmaCielo Announces Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2019
Apr 29, 2020

PharmaCielo Provides Details for Fourth Quarter and Year-End 2019 Results Conference Call
Apr 15, 2020

PharmaCielo Ltd. Announces Closing of Previously Announced $8 Million Private Placement Financing
Apr 6, 2020

PharmaCielo Ltd. Prices $8 Million Offering; Closing Scheduled for April 14
Apr 1, 2020

PharmaCielo Ltd. Announces Best Efforts Private Placement Offering
Mar 23, 2020

PharmaCielo Independent Investigation Concludes Short-seller Report Contains Accusations and Claims based on Faulty Interpretation of Events and Information
Mar 3, 2020

PharmaCielo Issues Statement Regarding Misleading Short Seller Report
Jan 27, 2020

PharmaCielo Announces 30,000 Kg Cannabis Extract Agreement for German Market
Jan 24, 2020

PharmaCielo Signs Pan-European Distribution Agreement for CBD Isolate and Broad-Spectrum CBD Oil
Jan 22, 2020

PharmaCielo Added to XCAN - the Newly Created S&P/TSX Cannabis Index
Jan 20, 2020

PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations
- Photos 1
Jan 17, 2020

PharmaCielo Receives Acceptance from TSX Venture Exchange of Supply Agreement for Export of 2018 Farm Bill-Compliant CBD Isolate to United States
Dec 14, 2019

PharmaCielo Awarded Game-Changer Award by MJDaily
Dec 5, 2019

PharmaCielo Announces Receipt of CAD$3.9 Million Secured Loan Repayment
Dec 2, 2019

PharmaCielo Graduates to OTCQX® Best Market and Secures DTC Eligibility
Nov 25, 2019

PharmaCielo to Hold Conference Call to Review Third Quarter 2019 Financial Results
Nov 25, 2019

PharmaCielo Announces Financial Results for the Three and Nine Months Ended September 30, 2019
Nov 8, 2019

PharmaCielo Announces RSU Grant
Nov 5, 2019

PharmaCielo Announces Termination of Scheme Implementation Agreement with Creso Pharma
Nov 4, 2019

PharmaCielo Trading Halted Pending Update from Creso Pharma
Nov 1, 2019

PharmaCielo Provides Update on Proposed Acquisition of Creso Pharma
Oct 2, 2019

PharmaCielo Announces Creso Pharma's Receipt of Australian Court Approval to Convene Meeting of Shareholders
Sep 25, 2019

PharmaCielo Enters the U.S. with $3 Million Q4 Sales Agreement and Completes Introductory Shipments to Multi-state Distributor General Extract LLC
Aug 27, 2019

PharmaCielo Announces Financial Results for the Second Quarter 2019
Aug 19, 2019

PharmaCielo's Very First Commercial CBD Export from Colombia Lands in Europe
Aug 13, 2019

PharmaCielo Expands Further Into Latin America With Sales Agreement to Supply CBD Extracts, Oils and Veterinary Products to Laboratorios Adler
- Photos 1
Aug 8, 2019

PharmaCielo Joins Canadian Market Cannabis Tracking and Verification Initiative
Aug 2, 2019

PharmaCielo Colombia Holdings S.A.S. Appoints New and Diversified Board of Directors
Aug 1, 2019

PharmaCielo Achieves Twelvefold Increase in Dried Cannabis Processing Capacity to Meet Global Demand for Medicinal Oil Extracts
Jul 26, 2019

PharmaCielo Completes Acquisition of Ubiquo Telemedicina
Jul 25, 2019

PharmaCielo First to Receive Colombian Government Export Approval for Commercial Sale of CBD Isolate
Jul 22, 2019

PharmaCielo Colombia Holdings S.A.S. Appoints Andres Felipe Botero as Chief Operations Officer
Jun 21, 2019

PharmaCielo Announces Trading on the OTC Market
Jun 6, 2019

PharmaCielo to Acquire International Cannabis Company Creso Pharma for A$122 Million
May 29, 2019

PharmaCielo Gears Up for U.S. Market Demand, Enlists Former Congressman and Medical Cannabis Advocate Dana Rohrabacher as a Special Advisor
May 27, 2019

PharmaCielo Announces its Financial Results for the First Quarter 2019
May 24, 2019

PharmaCielo Announces Results of AGM
Apr 18, 2019

PharmaCielo Announces its Financial Results for the Fourth Quarter and Fiscal Year 2018
Apr 9, 2019

PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board
Mar 29, 2019

PharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia's Cultivar Registration
Mar 19, 2019

PharmaCielo Receives ISO 9001 Quality Assurance Certification for its Medicinal Cannabis Cultivation and Processing Operations in Colombia
Feb 6, 2019

PharmaCielo Receives Approval for Cultivar Registration of 10 Proprietary Cannabis Strains
Jan 28, 2019

PharmaCielo Establishes Joint Venture with Mino Labs to Bring Medicinal Cannabis Oil to Mexico
Jan 18, 2019

PharmaCielo Begins Trading on the TSX Venture Exchange Under Ticker PCLO
Jan 16, 2019

PharmaCielo Ltd. Announces Completion of Qualifying Transaction
Jan 9, 2019

PharmaCielo Announces TSX Venture Listing and Provides Corporate Update
Dec 13, 2018

PharmaCielo to Produce 500-Year-Old Cannabis Strain in the Ancestral Territory of the Arhuaco

Show per page